CDKN2A and glioma: Pleomorphic xanthoastrocytoma is a circumscribed glial neoplasm that is genetically characterized by concurrent CDKN2A homozygous deletion and BRAF p.V600E mutation (or less commonly BRAF or RAF1 fusion) [29, 38].